Home | Back to newsletter main page

Bookmark and Share
Case Comprehensive Cancer Center Newsletter

November 7, 2011

CASE CCC IN THE NEWS

Charis Eng, MD, PhD, FACP: Leading the Way in Genomic Medicine
MD News - Nov 6, 2011
Dr. Charis Eng knew that she wanted to spend her working life in two places – the research bench and the patient bedside – even before the term ...

Oncology Group's Report Calls for Smaller, More-Tailored Clinical Trials
Plain Dealer - Nov 5, 2011
In May, less than a week after his dire diagnosis, the 39-year-old Hubbard man met with Dr. Neal Meropol, chief of the division of hematology and oncology ...

Axitinib Looks Good in Head-to-Head Renal Cancer Trial
MedPage Today - Nov 4, 2011
... patients getting axitinib had a median progression-free survival of 6.7 months, according to Brian Rini, MD, of the Cleveland Clinic, and colleagues. ...

Coulter Foundation, CWRU Establish $20M Endowment for Biomedical Engineering Projects
Case Daily - Nov 2, 2011
"The Coulter Process more closely resembles a business model," said Jeffrey L. Duerk, PhD, chairman of biomedical engineering at Case Western Reserve.


MARK YOUR CALENDARS

Cancer Center Seminar Series: Network Medicine: Can a network approach to cancer enable new targeting strategies, drug targets and biomarkers?
Haura

Friday, November 11
12-1 pm
Frohring Auditorium - BRB 105

Please join us Friday, November 11 at the next Cancer Center Seminar Series featuring Eric B. Haura, MD, Associate Professor of Medicine and Oncology at H. Lee Moffitt Cancer Center and Research Institute. Dr. Haura will present Network Medicine: Can a network approach to cancer enable new targeting strategies, drug targets and biomarkers?, during which he will describe the work his lab is doing using mass spectrometry-based proteomics to characterize cancer kinase signaling networks and the relationships with drugs. He will also describe ongoing efforts to develop protein-protein interaction biomarker strategies.

This seminar is hosted by the Developmental Therapeutics Program, but all are encouraged to attend. CME credit is available.


FUNDING OPPORTUNITIES

Robert Wood Johnson Foundation Community Health Leaders

Each year, the Robert Wood Johnson Foundation Community Health Leaders program honors up to 10 outstanding and otherwise unrecognized individuals who overcome daunting odds to improve health and health care, especially to underserved populations in communities across the United States. The program aims to elevate the work of these unsung leaders through heightened recognition, technical assistance and new leadership opportunities.

Deadline: November 28


ANNOUNCEMENTS

ASCO Report Stresses Need for More Targeted Approach to Clinical Trials

Dr. Neal Meropol was one of three executive editors of a newly released report by ASCO. Accelerating Progress Against Cancer, provides a high-level blueprint for transforming the translational and clinical cancer research system in the US. The report identifies and lays out plans to address three areas that are of immediate importance:

  • Establishing a new approach to therapeutic development, driven by our more thorough understanding of cancer biology
  • Designing smarter, faster clinical trials that are appropriate for the era of molecularly-targeted therapies
  • Harnessing information technology to seamlessly integrate clinical and translational research and patient care, ensuring that every patient's experience can inform research and improve care

Over the next three years, ASCO will work with partners throughout the cancer research community to develop more detailed plans of action for each of the three areas covered in the report.

Gifts to CWRU SOM Establish Professorship in Integrative Oncology

Today, the CWRU SOM announced gifts to establish the inaugural Parker Hannifin-Helen Moss Cancer Research Foundation Professorship in Integrative Oncology. The professorship seeks to change the way cancer is treated by employing the practice of integrative medicine and therapies designed to extend the lives of cancer patients using a more holistic and natural approach, along with traditional medicine.

The Parker Foundation partnered with the Helen Moss Cancer Research Foundation by donating $1 million to help establish the $1.5 million professorship. Helen Moss, a stage-four breast cancer survivor and founder of the Helen Moss Cancer Research Foundation, has spent the past 10 years advocating for integrative oncology. She is the driving force behind the establishment of this professorship, and her foundation is a sponsor of the upcoming Society for Integrative Oncology Conference in Cleveland.


NCI CANCER BULLETIN

November 1, 2011

News
Featured Article: Organ Transplant Recipients Are at Increased Risk for a Range of Cancers

Annual Screening with Chest X-Ray Does Not Reduce Lung Cancer Deaths

Radiation Therapy after Breast-Conserving Surgery Improves Survival

Targeted Therapy Shows Benefit in Rare Type of Thyroid Cancer

Study Confirms Letrozole Prevents More Breast Cancer Recurrences than Tamoxifen

Study Suggests Smaller Melanoma Excision Margins May Be Option for Some Patients

HPV Vaccine Reduces Anal HPV Infection and Precancerous Lesions

In Depth
Study Shows Aspirin Reduces Colorectal Cancer in Those at High Risk

Tackling the Conundrum of Cachexia in Cancer

Featured Clinical Trial: Cetuximab and Radiotherapy for HPV-Associated Oropharynx Cancer

Updates
CDC Update

Cancer.gov Update

Notes


NEWS FROM NIH

NIH Researchers Design a Light Therapy That Targets and Destroys Cancer Cells in Mice

Researchers have designed a light-based therapy that allows the selective destruction of tumor cells in mice without harming surrounding normal tissue.

EVENTS

calendar

**All events are open to anyone interested in attending

November 7

Pathology Graduate Student Seminar
Chao Fang
Schmaier Lab, Div. of Hem/Onc
CWRU/UH
Topic: Elevated NO Decreases Arterial Thrombosis Risk in B2R KO Mice by Reducing GPVI Activation
12 pm WRB 1-413

SDIG Meeting
Yunlong Liu, PhD
Adjunct Assistant Professor, Informatics
Assistant Professor, Medical & Molecular Genetics
Adjunct Assistant Professor, Medicine (Biostatistics)
Indiana University
Topic: Decipher Non-coding RNA Mediated Regulatory Network, an Application of Next Generation Sequencing Technology
2:30 pm WRB 1-402


November 8

Pathology Graduate Student Seminar
Mausita Karmakar
Pearlman Lab
CWRU
Topic: Neutrophil Mediated IL-1β Processing During P. aeruginosa Keratitis
AND
Andrew Lavik
Distelhorst Lab
Topic: The Role of IP3 Receptor-Interacting Proteins in Regulating IP3 Receptor-Dependent Calcium Signals and Cell Survival
12 pm WRB 1-413


November 9

Hematology and Oncology Division Research Conference
Ken Cooke, MD
Director, Pediatric BMT Program
Associate Professor, Pediatric Hematology/Oncology
CWRU/UH
Topic: Novel Approaches to Regulate GVHD
8 am Lerner B-151

Immunology Visiting Professor Seminar Series
Leo Lefrançois, PhD
Professor and Chairman, Immunology
University of Connecticut
Topic: It Takes Guts: Two Faces of Mucosal Memory T Cells
12 pm NC1-202 Cleveland Clinic


November 10


November 11

Hematology/Oncology Fellows Conference
Topic: TBD
8 am Wearn 137

Taussig Cancer Institute Grand Rounds
Richard Maziarz, MD
Medical Director, Adult Stem Cell Transplantation Program & Center for Hematologic Malignancies
Oregon Health and Science University
Topic: Can Adherent Stromal Cells Provide Efficacious Adjunctive Therapy in Hematopoietic Stem Cell Transplantation
8 am R3/002-003 Cleveland Clinic

Cancer Center Seminar Series
Eric B. Haura, MD
Associate Professor, Medicine and Oncology
H. Lee Moffitt Cancer Center and Research Institute
Topic: Network Medicine: Can a network approach to cancer enable new targeting strategies, drug targets and biomarkers?
12 pm BRB 105

Cancer Center Research in Progress Seminar
Tony Scott
Graduate Student, Wang Lab
CWRU/UH
Topic: Regulation of Paxillin Tyrosine-88 Phosphorylation in Colorectal Cancer Development
4 pm WRB 3-136

 

 

Case CCC Calendar

LRI Calendar


UPCOMING CANCER CENTER SYMPOSIUMS & EVENTS

 

ADDITIONAL UPCOMING SEMINARS & EVENTS

8th International Conference of the Society for Integrative Oncology: Innovating Integrative Oncology: New Science, New Solutions
November 10-12
InterContinental Hotel Cleveland
Details


PREVIOUSLY ANNOUNCED FUNDING OPPORTUNITIES

Robert Wood Johnson Foundation Health Policy Fellows program
Deadline: November 9

NCI Provocative Questions Project
Deadline: November 14

Rita Allen Foundation Scholars Program
Internal Deadline: November 14

AACR–Conquer Cancer Foundation of ASCO Young Investigator Translational Cancer Research Award
Deadline: November 15

Cellular Molecular Imaging of Cancer Pilot Funding: Cancer Microenvironment
Deadline Extended: November 17

SU2C-PCF Prostate Dream Team Translational Cancer Research Grant
LOI Deadline: November 28

Burroughs Wellcome Fund Collaborative Research Travel Grants
Deadline: December 1

CTSC Core Utilization pilot program
Deadline: December 1

Kimmel Scholar Award
Deadline: December 1

Kimmel Translational Science Award
Deadline: December 1

American Medical Association Seed Grant Research Program
Deadline: December 5

2012 NIH Director's Transformative Research Awards
LOI Deadline: December 12
Application Deadline: January 12, 2012

L'Oréal USA Fellowships For Women In Science
Deadline: December 15

Lymphatic Research Foundation (LRF) Postdoctoral Fellowship Program
Deadline: January 10, 2012

HHMI Medical Research Fellows Program
Deadline: January 11, 2012

2012 CTSC Annual Pilot Grant Funding
Mandatory LOI Deadline: January 15

Oncology Nursing Society Foundation Connie Henke Yarbro Excellence in Cancer Nursing Mentorship Award
Deadline: January 15, 2012

Robert Wood Johnson Foundation Executive Nurse Fellows
Deadline: January 18, 2012

Innovations for Health: Solutions that Cross Borders
Deadline: February 13, 2012

Translational Technology Concept Studies of Circulating Tumor and Endothelial Cells (CTC/CEC)
Deadline: Open

AACR Scholar-in-Training Awards - Other Conferences and Meetings
Deadline: Open

Case CCC Protocol Specific Research Support (PSRS)
Deadline: Open

International Union Against Cancer (UICC) International Cancer Technology Transfer Fellowships
Application Deadline: Open

International Waldenstrom's Macroglobulinemia Foundation (IWMF) Research Grant Program
Application Deadline: Open

NCI Short-Term Scientist Exchange Program
Application Deadline: Open


NIH BULLETIN – Notices and Funding Opportunities

Academic Research Enhancement Award (Parent R15) (PA-12-006)

Produced by:
Gillian Irwin Todd
11100 Euclid Avenue, Wearn 149
Cleveland, Ohio 44106-5065
216-844-8317 phone
216-844-7832 fax
gillian.irwin@case.edu

HELP US HELP YOU!

If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!

Send items to gillian.irwin@case.edu.